One Year Clinical Evaluation of White Spot Lesions Treated With Newly Introduced Resin Modified Glass Ionomer in Comparison to Resin Infiltration in Anterior Teeth Split Mouth Technique

NCT ID: NCT02912741

Last Updated: 2016-09-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-31

Study Completion Date

2018-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to evaluate the addition of new technology of resin modified glass-ionomer in comparison to resin infiltration in treating post-orthodontic white spot lesions; both applies into the same patient's mouth; to reveal which material will have more clinical satisfactory performance inside the oral cavity and to overcome the high expensive cost in treating such clinical cases

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Roles and responsibilities:

* Shaimaa Mohammed (SH.M.): Operator and author.Specialist in Air-Force Specialized Hospital.
* Mohamed Riad (M.R.): Main supervisor, data monitoring and auditing, Professor, Conservative Dentistry Department,Cairo University.
* Asma Harhash(A.H.):Co-supervisor, outcome assessor and data collection, Associate Professor, Russian University.
* Omnia Magdy Moustafa (O.M.): Baseline data collection, recruitment, sequence generation, allocation concealment, patient retention and taking participants consents: Assistant lecturer, Conservative Dentistry Department , Faculty of Oral and Dental Medicine Cairo University.
* Ghada Ahmed (G.A.): Data entry and auditing; Assistant lecturer, Conservative Dentistry Department, Faculty of Oral and Dental Medicine, Russian University.

Intervention:

A- Preoperative clinical assessment:

1. Explain patient need toward aesthetic needs
2. Digital photos for white spot lesions
3. Recording number of white spot lesions and site. (SH.M.) will apply both materials at the same patient mouth (Split mouth technique) according to the manufacturer's instructions.

* Intervention: resin modified glass ionomer cement varnish: Vanishâ„¢ xt Extended Contact Varnish (3M ESPE Dental)
* Comparator: resin infiltration (Dental Milestones Guaranteed, Germany).

(A.H) and (SH.M) will assess the outcome measures through the follow up time: immediately after,1 day, 1 week,1 month,3 months, 6 months, 12 months

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

White Spot Lesions

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vanish xt Extended Contact Varnish

Vanish xt Extended Contact Varnish is a resin modified glass ionomer cement and fluoride varnish used to treat white spot lesions to be more resistant to early caries progression.

Group Type EXPERIMENTAL

Vanish xt Extended Contact Varnish

Intervention Type DRUG

resin modified glass- ionomer cement varnish applied as a thin layer coating and cured

Resin infiltration

Resin infiltration is a low viscous resin infiltrates into small pores of white spot lesions to block entrance of bacteria into dentinal tubules of the tooth and more resistant to early caries progression.

Group Type ACTIVE_COMPARATOR

resin infiltration

Intervention Type DRUG

low viscous light cure resin applied in layers and cured

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vanish xt Extended Contact Varnish

resin modified glass- ionomer cement varnish applied as a thin layer coating and cured

Intervention Type DRUG

resin infiltration

low viscous light cure resin applied in layers and cured

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Clinpro xt ICON

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Post-Orthodontic patients included in this clinical trial toll age of 35 years.
2. Patients with good general health.
3. Patients who will agree to the consent and will commit to follow-up period.
4. Fully erupted anterior teeth with no cavitated lesions.
5. At least one spot lesion on each side in the same jaw

Exclusion Criteria

1. Patients with any systemic disease that may affect normal healing.
2. Patient with bad oral hygiene.
3. Tetracycline or fluorsis staining.
4. Patients who could/would not participate in all times of follow-up.
5. Untreated periodontal disease was not allowed.
6. Active caries or defective Restorations in 6 anterior teeth.
7. Bleaching history
8. Patients participating in more than 1 dental study.
9. Patient received fluoride varnish during orthodontic treatment.
Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Shaimaa Mohamed Mostafa Rohym

Specialist in Air-Force Specialized Hospital, New Cairo

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ahmed Elkhadem, PhD

Role: STUDY_CHAIR

Cairo University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Shaimaa Mohammed Rohym, Master

Role: CONTACT

01007374670

Asmaa Harhash, PHD

Role: CONTACT

01223325740

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEBD-CU-2016-09-209

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.